{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:45:23Z","timestamp":1792395923504,"version":"4.4.0"},"publisher-location":"Cham","reference-count":68,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030561529","type":"print"},{"value":"9783030561536","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-56153-6_15","type":"book-chapter","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T12:02:37Z","timestamp":1627732957000},"page":"251-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Clinical Use of Curcumin for the Treatment of Rheumatoid Arthritis: A Systematic Review of Clinical Trials"],"prefix":"10.1007","author":[{"given":"Mohammad","family":"Bagherniya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Darand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"issue":"6937","key":"15_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423(6937):356\u2013361","journal-title":"Nature"},{"issue":"5","key":"15_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/berh.2002.0257","volume":"16","author":"DP Symmons","year":"2002","unstructured":"Symmons DP (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16(5):707\u2013722","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"15_CR3","unstructured":"Symmons D, Mathers C, Pfleger B (2006) The global burden of rheumatoid arthritis in the year 2000. https:\/\/www.who.int\/healthinfo\/statistics\/bod_rheumatoidarthritis.pdf"},{"issue":"8","key":"15_CR4","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/13543776.2018.1502748","volume":"28","author":"RAD Oliveira","year":"2018","unstructured":"Oliveira RAD, Fierro IM (2018) New strategies for patenting biological medicines used in rheumatoid arthritis treatment. Expert Opin Ther Pat 28(8):635\u2013646","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"15_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/rheumatology\/39.1.28","volume":"39","author":"N Cooper","year":"2000","unstructured":"Cooper N (2000) Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 39(1):28\u201333","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"15_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/s10165-007-0604-9","volume":"17","author":"N Haroon","year":"2007","unstructured":"Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R (2007) Impact of rheumatoid arthritis on quality of life. Mod Rheumatol 17(4):290\u2013295","journal-title":"Mod Rheumatol"},{"issue":"3","key":"15_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5152\/eurjrheum.2018.17111","volume":"5","author":"B Paul","year":"2018","unstructured":"Paul B, Pariyapurath R (2018) Risk factor assessment of rheumatoid arthritis in North Kerala. Eur J Rheumatol 5(3):184\u2013190","journal-title":"Eur J Rheumatol"},{"issue":"6","key":"15_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA et al (2018) Rheumatoid arthritis: a brief overview of the treatment. Med Prin Pract 27(6):501\u2013507","journal-title":"Med Prin Pract"},{"issue":"7","key":"15_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1517\/13543776.18.7.723","volume":"18","author":"L-D Quan","year":"2008","unstructured":"Quan L-D, Thiele GM, Tian J, Wang D (2008) The development of novel therapies for rheumatoid arthritis. Expert Opin Ther Pat 18(7):723\u2013738","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"15_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00296-009-1206-y","volume":"30","author":"P Efthimiou","year":"2010","unstructured":"Efthimiou P, Kukar M (2010) Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int 30(5):571\u2013586","journal-title":"Rheumatol Int"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","volume":"130","author":"M Bagherniya","year":"2018","unstructured":"Bagherniya M, Nobili V, Blesso CN, Sahebkar A (2018) Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review. Pharmacol Res 130:213\u2013240","journal-title":"Pharmacol Res"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.22159\/ijap.2019.v11s6.33578","volume":"11","author":"A Fahira","year":"2019","unstructured":"Fahira A, Soraya A, Achmadsyah A, Hakim RW (2019) Efficacy and safety of Curcuma longa extract in the treatment of osteoarthritis: a systematic review. Int J Appl Pharm 11:140\u2013145","journal-title":"Int J Appl Pharm"},{"issue":"2","key":"15_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcp.25778","volume":"233","author":"E Abdollahi","year":"2018","unstructured":"Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A (2018) Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? J Cell Physiol 233(2):830\u2013848","journal-title":"J Cell Physiol"},{"issue":"2","key":"15_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13813450802033958","volume":"114","author":"L Pari","year":"2008","unstructured":"Pari L, Tewas D, Eckel J (2008) Role of curcumin in health and disease. Arch Physiol Biochem 114(2):127\u2013149","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"15_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101","journal-title":"Crit Rev Food Sci Nutr"},{"key":"15_CR16","doi-asserted-by":"crossref","unstructured":"Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors 43(3):331\u2013346\u00a0","DOI":"10.1002\/biof.1344"},{"key":"15_CR17","doi-asserted-by":"crossref","unstructured":"Momtazi AA, Derosa G, Maffioli P, Banach M, Sahebkar A (2016) Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20(4):335\u2013345","DOI":"10.1007\/s40291-016-0202-7"},{"key":"15_CR18","doi-asserted-by":"crossref","unstructured":"Soleimani V, Sahebkar A, Hosseinzadeh H (2018) Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother Res 32(6):985\u2013995. https:\/\/doi.org\/10.1002\/ptr.6054. Epub 2018 Feb 26. PMID: 29480523","DOI":"10.1002\/ptr.6054"},{"issue":"8","key":"15_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/cjoc.20040220812","volume":"22","author":"YM Sun","year":"2004","unstructured":"Sun YM, Wang RX, Yuan SL, Lin XJ, Liu CB (2004) Theoretical study on the antioxidant activity of curcumin. Chin J Chem 22(8):827\u2013830","journal-title":"Chin J Chem"},{"issue":"6","key":"15_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.2042-7158.1973.tb09131.x","volume":"25","author":"R Srimal","year":"1973","unstructured":"Srimal R, Dhawan B (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25(6):447\u2013452","journal-title":"J Pharm Pharmacol"},{"key":"15_CR21","doi-asserted-by":"crossref","unstructured":"Hasanzadeh S, Read MI, Bland AR, Majeed M, Jamialahmadi T, Sahebkar A (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921. https:\/\/doi.org\/10.1016\/j.phrs.2020.104921. Epub 2020 May 25. PMID: 32464325.","DOI":"10.1016\/j.phrs.2020.104921"},{"issue":"7","key":"15_CR22","first-page":"1176","volume":"8","author":"FJ Fagbemi","year":"2009","unstructured":"Fagbemi FJ, Ugoji E, Adenipekun T et al (2009) Evaluation of the antimicrobial properties of unripe banana (Musa sapientum L.), lemon grass (Cymbopogon citratus S.) and turmeric (Curcuma longa L.) on pathogens. Afr J Biotechnol 8(7):1176\u20131182","journal-title":"Afr J Biotechnol"},{"key":"15_CR23","doi-asserted-by":"crossref","unstructured":"Forouzanfar F, Read MI, Barreto GE, Sahebkar A (2020) Neuroprotective effects of curcumin through autophagy modulation. IUBMB Life 72(4):652\u2013664. https:\/\/doi.org\/10.1002\/iub.2209. Epub 2019 Dec 5. PMID: 31804772","DOI":"10.1002\/iub.2209"},{"key":"15_CR24","doi-asserted-by":"crossref","unstructured":"Bagheri H, Ghasemi F, Barreto GE, Rafiee R, Sathyapalan T, Sahebkar A (2020) Effects of curcumin on mitochondria in neurodegenerative diseases. Biofactors 46(1):5\u201320. https:\/\/doi.org\/10.1002\/biof.1566. Epub 2019 Oct 3. PMID: 31580521","DOI":"10.1002\/biof.1566"},{"key":"15_CR25","doi-asserted-by":"crossref","unstructured":"Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H (2010)\u00a0Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17(3\u20134):269\u201373. https:\/\/doi.org\/10.1016\/j.phymed.2009.05.020. Epub 2009 Jul 3. PMID: 19577457","DOI":"10.1016\/j.phymed.2009.05.020"},{"issue":"28","key":"15_CR26","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.2174\/1381612822666160527113501","volume":"22","author":"AA Momtazi","year":"2016","unstructured":"Momtazi AA, Sahebkar A (2016) Difluorinated curcumin: a promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des 22(28):4386\u20134397","journal-title":"Curr Pharm Des"},{"key":"15_CR27","doi-asserted-by":"crossref","unstructured":"Mohajeri M, Bianconi V, \u00c1vila-Rodriguez MF, Barreto GE, Jamialahmadi T, Pirro M, Sahebkar A (2020) Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res 156:104765. https:\/\/doi.rg\/10.1016\/j.phrs.2020.104765. Epub 2020 Mar 23. PMID: 32217147","DOI":"10.1016\/j.phrs.2020.104765"},{"issue":"3","key":"15_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.intimp.2010.08.014","volume":"11","author":"RM Srivastava","year":"2011","unstructured":"Srivastava RM, Singh S, Dubey SK, Misra K, Khar A (2011) Immunomodulatory and therapeutic activity of curcumin. Int Immunopharmacol 11(3):331\u2013341","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"15_CR29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1089\/jmf.2017.3930","volume":"20","author":"A Amalraj","year":"2017","unstructured":"Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ et al (2017) A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J Med Food 20(10):1022\u20131030","journal-title":"J Med Food"},{"issue":"4","key":"15_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jtcme.2018.06.001","volume":"9","author":"J Jacob","year":"2019","unstructured":"Jacob J, Amalraj A, Raj KJ, Divya C, Kunnumakkara AB, Gopi S (2019) A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite\u2122) improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double blind and placebo controlled study. J Tradit Complement Med 9(4):346\u2013352","journal-title":"J Tradit Complement Med"},{"issue":"11","key":"15_CR31","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"B Chandran","year":"2012","unstructured":"Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719\u20131725","journal-title":"Phytother Res"},{"key":"15_CR32","first-page":"389","volume":"7","author":"AA Hemmati","year":"2016","unstructured":"Hemmati AA, Rajaee E, Houshmand G, Fakhroddin MA, Dargahi-MalAmir M, Hesam S et al (2016) Study the effects of anti-inflammatory curcumex capsules containing three plants (ginger, curcumin and black pepper) in patients with active rheumatoid arthritis. IIOAB J 7:389\u2013392","journal-title":"IIOAB J"},{"issue":"10","key":"15_CR33","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/1756-185X.13688","volume":"22","author":"M Javadi","year":"2019","unstructured":"Javadi M, Khadem Haghighian H, Goodarzy S, Abbasi M, Nassiri-Asl M (2019) Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: a randomized, double-blind, controlled trial. Int J Rheum Dis 22(10):1857\u20131862","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"15_CR34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"issue":"1","key":"15_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312","journal-title":"Control Clin Trials"},{"issue":"12","key":"15_CR36","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta3120","volume":"3","author":"D Moher","year":"1999","unstructured":"Moher D, Cook D, Jadad A, Tugwell P, Moher M, Jones A et al (1999) Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess 3(12):i\u2013iv. 1\u201398","journal-title":"Health Technol Assess"},{"issue":"4","key":"15_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/ijdr.IJDR_662_17","volume":"30","author":"D Anusha","year":"2019","unstructured":"Anusha D, Chaly P, Junaid M, Nijesh J, Shivashankar K, Sivasamy S (2019) Efficacy of a mouthwash containing essential oils and curcumin as an adjunct to nonsurgical periodontal therapy among rheumatoid arthritis patients with chronic periodontitis: a randomized controlled trial. Indian J Dent Res 30(4):506\u2013511","journal-title":"Indian J Dent Res"},{"issue":"10","key":"15_CR38","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/acr.23171","volume":"69","author":"H Radner","year":"2017","unstructured":"Radner H, Lesperance T, Accortt NA, Solomon DH (2017) Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis. Arthritis Care Res (Hoboken) 69(10):1510\u20131518","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"15_CR39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.apnu.2015.04.003","volume":"29","author":"M Iaquinta","year":"2015","unstructured":"Iaquinta M, McCrone S (2015) An integrative review of correlates and predictors of depression in patients with rheumatoid arthritis. Arch Psychiatr Nurs 29(5):265\u2013278","journal-title":"Arch Psychiatr Nurs"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12891-016-1011-1","volume":"17","author":"F Matcham","year":"2016","unstructured":"Matcham F, Ali S, Irving K, Hotopf M, Chalder T (2016) Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study. BMC Musculoskelet Disord 17:155. https:\/\/doi.org\/10.1186\/s12891-016-1011-1","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"15_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejr.2013.12.007","volume":"36","author":"F Rezaei","year":"2014","unstructured":"Rezaei F, Doost HTN, Molavi H, Abedi MR, Karimifar M (2014) Depression and pain in patients with rheumatoid arthritis: mediating role of illness perception. Egypt Rheumatol 36(2):57\u201364","journal-title":"Egypt Rheumatol"},{"issue":"9","key":"15_CR42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-008-0551-6","volume":"28","author":"B Tander","year":"2008","unstructured":"Tander B, Cengiz K, Alayli G, \u0130lhanli \u0130, Canbaz S, Canturk F (2008) A comparative evaluation of health related quality of life and depression in patients with fibromyalgia syndrome and rheumatoid arthritis. Rheumatol Int 28(9):859\u2013865","journal-title":"Rheumatol Int"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"b702","DOI":"10.1136\/bmj.b702","volume":"338","author":"C Deighton","year":"2009","unstructured":"Deighton C, O\u2019Mahony R, Tosh J, Turner C, Rudolf M (2009) Management of rheumatoid arthritis: summary of NICE guidance. BMJ 338:b702. https:\/\/doi.org\/10.1136\/bmj.b702","journal-title":"BMJ"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"1):1","DOI":"10.1038\/s41413-018-0009-8","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6:1):1\u20131)14","journal-title":"Bone Res"},{"issue":"3","key":"15_CR45","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12072-018-9910-x","volume":"13","author":"Z Wei","year":"2019","unstructured":"Wei Z, Liu N, Tantai X, Xing X, Xiao C, Chen L et al (2019) The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Hepatol Int 13(3):302\u2013313","journal-title":"Hepatol Int"},{"issue":"2","key":"15_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/biof.1062","volume":"39","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A (2013) Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors 39(2):197\u2013208","journal-title":"BioFactors"},{"issue":"1","key":"15_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12937-017-0293-y","volume":"16","author":"S Qin","year":"2017","unstructured":"Qin S, Huang L, Gong J, Shen S, Huang J, Ren H et al (2017) Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J 16(1):68. https:\/\/doi.org\/10.1186\/s12937-017-0293-y","journal-title":"Nutr J"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"104505","DOI":"10.1016\/j.phrs.2019.104505","volume":"150","author":"A Hadi","year":"2019","unstructured":"Hadi A, Pourmasoumi M, Ghaedi E, Sahebkar A (2019) The effect of Curcumin\/Turmeric on blood pressure modulation: a systematic review and meta-analysis. Pharmacol Res 150:104505. https:\/\/doi.org\/10.1016\/j.phrs.2019.104505","journal-title":"Pharmacol Res"},{"issue":"4","key":"15_CR49","doi-asserted-by":"publisher","first-page":"e0215840","DOI":"10.1371\/journal.pone.0215840","volume":"14","author":"N Poolsup","year":"2019","unstructured":"Poolsup N, Suksomboon N, Kurnianta PDM, Deawjaroen K (2019) Effects of curcumin on glycemic control and lipid profile in prediabetes and type 2 diabetes mellitus: a systematic review and meta-analysis. PLoS One 14(4):e0215840. https:\/\/doi.org\/10.1371\/journal.pone.0215840","journal-title":"PLoS One"},{"issue":"10","key":"15_CR50","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","volume":"121","author":"P Libby","year":"2008","unstructured":"Libby P (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med 121(10):S21\u2013S31","journal-title":"Am J Med"},{"issue":"6","key":"15_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7(6):429\u2013442","journal-title":"Nat Rev Immunol"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","volume":"107","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Cicero AF, Simental-Mend\u00eda LE, Aggarwal BB, Gupta SC (2016) Curcumin downregulates human tumor necrosis factor-\u03b1 levels: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 107:234\u2013242","journal-title":"Pharmacol Res"},{"issue":"5","key":"15_CR53","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ptr.5045","volume":"28","author":"A Sahebkar","year":"2014","unstructured":"Sahebkar A (2014) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 28(5):633\u2013642","journal-title":"Phytother Res"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.phrs.2016.07.004","volume":"111","author":"G Derosa","year":"2016","unstructured":"Derosa G, Maffioli P, Simental-Mendia LE, Bo S, Sahebkar A (2016) Effect of curcumin on circulating interleukin-6 concentrations: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 111:394\u2013404","journal-title":"Pharmacol Res"},{"issue":"6","key":"15_CR55","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1381612822666161006151605","volume":"23","author":"M Ghandadi","year":"2017","unstructured":"Ghandadi M, Sahebkar A (2017) Curcumin: an effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921\u2013931","journal-title":"Curr Pharm Des"},{"issue":"4","key":"15_CR56","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM et al (2014) Rheumatoid factor as a potentiator of anti\u2013citrullinated protein antibody\u2013mediated inflammation in rheumatoid arthritis. Arthritis Rheum 66(4):813\u2013821","journal-title":"Arthritis Rheum"},{"issue":"2\u20133","key":"15_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.imlet.2004.03.018","volume":"93","author":"LF Bovin","year":"2004","unstructured":"Bovin LF, Rieneck K, Workman C, Nielsen H, S\u00f8rensen SF, Skj\u00f8dt H et al (2004) Blood cell gene expression profiling in rheumatoid arthritis: discriminative genes and effect of rheumatoid factor. Immunol Lett 93(2\u20133):217\u2013226","journal-title":"Immunol Lett"},{"issue":"3","key":"15_CR58","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/08923970500242244","volume":"27","author":"V Yadav","year":"2005","unstructured":"Yadav V, Mishra K, Singh D, Mehrotra S, Singh V (2005) Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 27(3):485\u2013497","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"8","key":"15_CR59","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/jmf.2016.3705","volume":"19","author":"JW Daily","year":"2016","unstructured":"Daily JW, Yang M, Park S (2016) Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food 19(8):717\u2013729","journal-title":"J Med Food"},{"issue":"S5","key":"15_CR60","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1002\/art.11407","volume":"49","author":"J Fransen","year":"2003","unstructured":"Fransen J, Stucki G, van Riel PL (2003) Rheumatoid arthritis measures: disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI). Arthritis Care Res 49(S5):S214\u2013S224","journal-title":"Arthritis Care Res"},{"issue":"2","key":"15_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45(2):27\u201337","journal-title":"Int Anesthesiol Clin"},{"issue":"Suppl. 2","key":"15_CR62","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s10072-006-0582-2","volume":"27","author":"M Longoni","year":"2006","unstructured":"Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27(Suppl. 2):S107\u2013S110","journal-title":"Neurol Sci"},{"issue":"4","key":"15_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ptr.2662","volume":"23","author":"N Mittal","year":"2009","unstructured":"Mittal N, Joshi R, Hota D, Chakrabarti A (2009) Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res 23(4):507\u2013512","journal-title":"Phytother Res"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejphar.2013.11.033","volume":"723","author":"HR Banafshe","year":"2014","unstructured":"Banafshe HR, Hamidi GA, Noureddini M, Mirhashemi SM, Mokhtari R, Shoferpour M (2014) Effect of curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. Eur J Pharmacol 723:202\u2013206","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"15_CR65","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ptr.2070","volume":"21","author":"S Sharma","year":"2007","unstructured":"Sharma S, Chopra K, Kulkarni SK (2007) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother Res 21(3):278\u2013283","journal-title":"Phytother Res"},{"issue":"3","key":"15_CR66","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejphar.2006.03.006","volume":"536","author":"S Sharma","year":"2006","unstructured":"Sharma S, Kulkarni SK, Agrewala JN, Chopra K (2006) Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 536(3):256\u2013261","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"15_CR67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.7150\/ijms.5224","volume":"10","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang Y, Liu DB, Liu HY, Hou WG, Dong YS (2013) Curcumin attenuates diabetic neuropathic pain by downregulating TNF-\u03b1 in a rat model. Int J Med Sci 10(4):377\u2013381","journal-title":"Int J Med Sci"},{"issue":"1","key":"15_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/advances\/nmx011","volume":"9","author":"AL Lopresti","year":"2018","unstructured":"Lopresti AL (2018) The problem of curcumin and its bioavailability: could its gastrointestinal influence contribute to its overall health-enhancing effects? Adv Nutr 9(1):41\u201350","journal-title":"Adv Nutr"}],"container-title":["Advances in Experimental Medicine and Biology","Studies on Biomarkers and New Targets in Aging Research in Iran"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-56153-6_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T14:06:32Z","timestamp":1627740392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-56153-6_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030561529","9783030561536"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-56153-6_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"1 August 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}